Risk of male breast cancer in users of testosterone 5a reductase inhibitors

Medicin och livsvetenskap

• Male Breast Neoplasms 100%
• Oxidoreductases 63%
• Testosterone 61%
• Adrenergic Antagonists 31%
• Gynecomastia 26%
• Hyperplasia 16%
• Prostate 15%
• Androgen Receptors 6%
• Neoplasms 6%
• Pharmaceutical Preparations 5%
• Prostatic Neoplasms 5%
• Hormones 4%
• Logistic Models 4%
• Breast Neoplasms 4%
• Mutation 3%
• Population 2%
• Therapeutics 1%